News & events

Tumor-LN-oC M30 Meeting in Neuchâtel
November 16, 2023
At last week’s M30 consortium meeting, Tumor-LN-oC partners presented progress in R+D activities & jointly solved challenges for the integration of all individu
Wrap-up of 2023 conference season
October 22, 2023
During the 2023 Conference season, Tumor-LN-oC partners were busy presenting their activities and progress in this interdisciplinary project! Among others, we w
M24 Meeting – Already 2 years into the project!
May 15, 2023
Last week, our consortium gathered in Turku, Finland for the Tumor-LN-oC M24 project meeting, hosted by Åbo Akademi University in the oldest city in Finland! T
Tumor-LN-oC is on Zenodo!
April 6, 2023
Tumor-LN-oC latest achievements, technical results and scientific outputs will be published on the Tumor-LN-oC community on Zenodo. The first two, recently pu
PhosPrint selected as finalist for the SPIE Startup Challenge
December 12, 2022
Our consortium partner PhosPrint was selected as one of the finalists of the 13th annual SPIE Startup Challenge! The final pitch presentations will take place
M18 project meeting and first successful review
December 1, 2022
After 1.5 years of project implementation, the Tumor-LN-oC consortium recently gathered in Athens for the M18 project meeting. The 2-day consortium meeting w
Tumor-LN-oC at the Regenerative Medicine workshop 12.10.22 in Prague
July 20, 2022
Tumor-LN-oC partner AMIRES kindly invites you to the 2nd Regenerative Medicine workshop which will take place on Wednesday, October 12th 2022, in Prague. Reg
Working towards a Tumor-Lymph Node-On chip platform – Progress and achievements after 1 Year of Tumor-LN-oC
May 18, 2022
From 12-14 May 2022, the Tumor-LN-oC consortium met at TU/e in Eindhoven for the project’s M12 progress meeting. The Meeting officially concluded the first year
Tumor-LN-oC contribution to an innovative and resilient health industry in Europe highlighted for #WorldHealthDay
April 26, 2022
The European Health and Digital Executive Agency (HaDEA) has featured Tumor-LN-oC in a special article on its website for World Health Day. The agency underline
Laser bioprinting: a key technology for recapitulating tissue and cell functions
April 12, 2022
As one of the components of the Tumor-LN-oC platform, consortium partner PhosPrint is working on a laser bioprinting process for OrganOnChip (OoC) and sensor ap